ARTICLE | Clinical News
Primatized: Commenced Phase I trial
August 9, 1993 7:00 AM UTC
IDEC Pharmaceuticals Corp. (IDPH) Product: Primatized, anti-CD4 antibody Indication: Rheumatoid arthritis Status: Commenced Phase I trial Note: The initiation of clinical trials triggered a $2 millio...